Amantrel Antiviral Drug

Get a Price/Quote

MOQ : 10000000 Pieces

Amantrel Antiviral Drug Trade Information

Minimum Order Quantity
10000000 Pieces

Payment Terms
Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)

Supply Ability
10000000 Pieces Per Week

Delivery Time
1 Week

Packaging Details
30 ML

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Certifications
WHO GMP COA FSC

About Amantrel Antiviral Drug

Amantrel is an antiparkinsonian and antiviral drug, a tricyclic symmetric adamantanamin. This medication blocks glutamate NMDA-receptors, thus reducing the excessive stimulatory effect of cortical glutamate neurons in the neostriatum that develops against the backdrop of lack of dopamine.

Amantrel inhibits NMDA-receptors in the neurons of the substantia nigra, reduces the intake of Ca ions, which reduces the possibility of destruction of these neurons. In a greater Amantrel influences on stiffness (rigidity and bradykinesia).

This medicine inhibits the penetration of Influenza A virus into the cell.

Indications:

Parkinsonism
Influenza A
Herpes zoster infections
Symptomatic treatment of several forms of Parkinson disease or syndrome
Drug-induced extrapyramidal reactions
Prevention and treatment of Influenza A viral respiratory illness, especially in high-risk patients

Additional Notes:

Amantrel, an antiviral drug, is prescribed for the prevention and treatment of Influenza A infection. However, the drug should not be used to treat all seasonal flu cases to avoid drug-resistance.

Amantrel is also indicated for management of Parkinson disease and iatrogenic extrapyramidal reactions.

Active Ingredient: